Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fimmu.2021.613422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID‐19 and the Canadian cattle/beef sector: Some preliminary analysis
- (2020) James Rude CANADIAN JOURNAL OF AGRICULTURAL ECONOMICS-REVUE CANADIENNE D AGROECONOMIE
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Review of trials currently testing treatment and prevention of COVID-19
- (2020) Paraskevi C. Fragkou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
- (2020) Tao Liu et al. EMBO Molecular Medicine
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- COVID-19 as an Acute Inflammatory Disease
- (2020) Rose H. Manjili et al. JOURNAL OF IMMUNOLOGY
- Elevated Interleukin‐6 and Severe COVID‐19: A Meta‐Analysis
- (2020) Muhammad Aziz et al. JOURNAL OF MEDICAL VIROLOGY
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- IL-6–based mortality risk model for hospitalized patients with COVID-19
- (2020) Rocio Laguna-Goya et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Focus shifts to antibody cocktails for COVID-19 cytokine storm
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Weathering the Cytokine Storm in COVID-19: Therapeutic Implications
- (2020) Giulia Iannaccone et al. CardioRenal Medicine
- Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19
- (2020) Zeming Liu et al. Frontiers in Pharmacology
- Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
- (2020) Alessandra Vultaggio et al. Journal of Allergy and Clinical Immunology-In Practice
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-6 as prognosticator in patients with COVID-19
- (2020) Elisa Grifoni et al. JOURNAL OF INFECTION
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 and COVID-19: From the Bench to the Bedside
- (2020) Stefano Romagnoli et al. PHYSIOLOGICAL REVIEWS
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
- (2020) Lorenzo Salvati et al. IMMUNOLOGY LETTERS
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
- (2020) Imad M. Tleyjeh et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Role of Interleukin 6 During Viral Infections
- (2019) Lauro Velazquez-Salinas et al. Frontiers in Microbiology
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
- (2017) Edward M. Behrens et al. Arthritis & Rheumatology
- Immunotherapeutic implications of IL-6 blockade for cytokine storm
- (2016) Toshio Tanaka et al. Immunotherapy
- Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
- (2012) O Dienz et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More